Ani Pharmaceuticals reported $84.87M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Ani Pharmaceuticals ANIP:US $ 84.87M 4.58M
Aurora Cannabis Inc ACB:CN 120.39M 4.02M
Biodelivery Sciences International BDSI:US $ 77.66M 13.75M
Canopy Growth Corp WEED:CN C$ 259.9M 3.77M
Depomed DEPO:US $ 100.48M 16.43M
Eli Lilly And LLY:US $ 13682M 1411.2M
Emergent Biosolutions EBS:US $ 365.4M 12.4M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
Hikma Pharmaceutical HIK:LN 960M 68M
Knight Therapeutics Inc GUD:CN C$ 132.55M 14.78M
Lannett LCI:US $ 112.28M 21.81M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Novartis NVS:US $ 29880M 247M
Omeros OMER:US $ 42.82M 4.88M
Perrigo Ordinary Shares PRGO:US $ 2003.8M 19.3M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M